https://www.selleckchem.com/products/didox.html
The objective of this study was to explore and validate thresholds for Placental growth factor (PlGF) and soluble fms-like tyrosine-kinase 1 (s-Flt-1) (as s-Flt-1 PlGF ratio), to rule-in and rule-out disease in women with suspected pre-eclampsia, using DELFIA® Xpress PlGF1-2-3 and sFlt-1 assays. 369 samples from women with suspected or confirmed pre-eclampsia were analysed from a prospective cohort study. Serum PlGF and sFlt-1 PlGF were quantified using DELFIA® Xpress PlGF1-2-3 and DELFIA® Xpress sFlt-1 tests. Performances were evaluated
Like
Comment
Share
